Posted by AGORACOM-JC
at 12:14 PM on Wednesday, June 23rd, 2021
To understand Awakn you first have to understand that …. Psychedelics are going to go through a parabolic, paradigm shifting growth in the next 5 years because of their ability to treat anxiety, depression and addiction … amongst other things Awakn Life Sciences is a biotechnology company with clinical operations developing, and delivering psychedelic medicine to better treat Addiction.
Awakn has a dual strategic focus:
Development: Research & developing the next generation of psychedelic drugs, therapies, and enabling technologies to better treat Addiction.
Delivery: Awakn will deliver evidence backed psychedelic therapies for Addiction in clinics in the UK and Europe and through licensing partnerships globally.
Notable Highlights include:
Strategic focus on better treating Addiction with psychedelics.
World leading team focused on psychedelic drug and therapy research.
Strong drug and therapy development pipeline, specifically targeting Addiction.
Clinics, which will be the UK and EU’s leading medical psychedelic therapy delivery
Closed $8.3M June 8
BRAND NEW LISTING … commencing trading on NEO
Sit back, relax and watch this powerful interview with CEO Anthony Tennyson.
Posted by AGORACOM-JC
at 9:06 AM on Saturday, June 19th, 2021
A weekly summary of Novamind news and media, including the announcement of a US$1,000,000 strategic investment in a Stealth Mode Drug Development Company.
“Novamind has over five years of operational expertise with psychedelic medicine, a track record of innovative treatment protocol development, and strong clinical research partnerships with blue-chip pharmaceutical companies,” said CEO Yaron Conforti. “I’m excited to share our vision for the next chapter of mental health treatment at the Conference.”
The Strategic Investment leverages Novamind’s expertise in patient recruitment and patient management for the Investee’s development of novel treatments for neuropsychiatric disorders.
Global News paints a compelling picture about the need for psychedelic-assisted therapy in Canada. “I just had so many different experiences, where all my questions that I had written out, everything was answered for me.” says Laurie Brooks, who was diagnosed with colon cancer at age 54. “I’m able now to deal with the emotions as they come, and to sit with them and hold them.”
It’s been a year of progress as many health breakthroughs happened while the public’s attention was rightfully focused on a Covid vaccine. Time covers some significant steps forward, including a malaria vaccine that could help save some 400,000 lives a year and the promising results of MDMA and psilocybin studies. It’s important to note the therapy aspect of the psychedelic studies. Both MDMA and psilocybin were given to participants in conjunction with therapy. Yes, these drugs are powerful and help provide the right mindset for improving mental health, but it’s the therapy that really creates lasting change. And it’s why that’s such a big part of what we do at Novamind.
Congratulations to Atai Life on listing to the Nasdaq. As an early strategic investor, we look forward to seeing Atai continue to deliver on its mission of “pioneering the development of highly effective mental health treatments.” Christian Angermayer
Posted by AGORACOM
at 7:00 PM on Sunday, June 13th, 2021
American Creek ( AMK:TSXV ) is located in one of the best mining jurisdictions in the world in B.C. Canada. They are already partnered to a world class discovery and just embarked on this years exploration program to determine how big their Goldstorm deposit really is, and to see if the deposit is not alone. There may yet be a whole storm of deposits out there on the property.
The Treaty Creek project is in the Golden Triangle on one of the largest hydrothermal systems in the world. The “Sulphurets Hydrothermal system” supports numerous world scale deposits, including the high-grade Brucejack mine (opened 2017 by Pretivm) and Seabridge’s KSM which boasts the largest undeveloped gold deposit by reserves in the world.
The southern half of the system contains 188m oz gold, 1.2 bn oz silver, 55bn lbs. copper in resources.
American Creeks Treaty Creek project is a Joint Venture. Tudor Gold owns 3/5th, is the operator and controls all costs associated with development and discovery. American Creek owns 20% and is fully carried until a “Production Notice” is issued and benefits from a “free ride” on any discovery, or discoveries made, to which there is one to date.
In March the 1st the very first resource calculation was released for Treaty Creek’s Goldstorm deposit. It is true world class, opening with 19.4m ounces of gold equivalent in Indicated and 7.9m Inferred. The potential to grow with further drilling is substantial.
A 2021 Phase 1, 30,00m, 4 drill program is underway to define where the mineralization stops in order to truly define the scope of the Goldstorm deposit. It is still open in all directions. Not too many companies have the advantage of this position, let alone at no cost.
There will be 2 more drills and 20,000 more metres added to the program later this summer targeting new discoveries.
Last Year Eric Sprott said the following about the Goldstorm Deposit on Treaty Creek:”
“It certainly looks like they have 20 million ounces and they could easily get to 30 or 40 or 50 million ounces (of gold)” Eric Sprott, July 24, 2020
I wonder how many ounces he will be counting at the end of this drill campaign. Or will it be discoveries?
Drop in and enjoy this illustrative narrative with Kelvin Burton of American Creek and discover the world class scale of Treaty Creek.
Green Market Report covers our fiscal Q3 earnings in their Psychedellux recap of the top business stories in the psychedelic medicine industry.
Novamind reported total revenue of $1.8 million, a 43% quarter-over-quarter, driven by increased patient volume at the Company’s four operating clinics.
“Together with the Wholeness Center, we’re joining forces to offer a new therapy that will positively impact the people who show up every day and continue to provide critical healthcare for the public during—and after—this difficult time,” said Dr. Robison.
From GQ’s series on mental health comes a piece about the psychological reasons how new experiences can change how we perceive time and make us more resilient. It’s an interesting read and the author even compares trees blooming in spring to psychedelics. “Even the most mundane new experiences left me feeling genuinely elated.” There’s a reason for it too. From Dr. Laurie Santos, “Novel stimuli tend to activate regions of our brain that are associated with rewards.” At our Cedar Psychiatry clinics, we practice a holistic approach to mental health. Taking into account psychological, biological, social, environmental, and cultural influences. Learn more here.
We’ve always believed in Atai’s vision to transform the treatment of mental health disorders. It’s why we became early strategic investment partners. Congratulations to Atai Life Sciences on launching their initial public offering.
Posted by AGORACOM-JC
at 5:10 PM on Thursday, June 10th, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:
” Demand for higher purity Silicon, materials that the PUREVAP QRR was designed to produce – but one that traditional silicon producers have a difficult time making, is about to enter a massive growth phase, driven by worldwide demand from the silicones, solar, and batteries industries. The Covid-19 pandemic accelerated the closing of old inefficient traditional Silicon plants and combining this with the chronic under investment in new conventional Silicon plants that occurred in the past decade, and the need for more efficient and environmentally friendly processes has created a perfect storm for the industry. HPQ should be a key beneficiary of this new reality.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted in AGORACOM Via Satellite, HPQ-Silicon Resources Inc. | Comments Off on VIDEO – HPQ Silicon $HPQ.ca $HPQFF Hits Another Silicon Production Milestone As Pilot Plant Starts In Q4, Moving Company Closer To Awaiting Battery and Automobile Manufacturers $ENPH $NNO
Posted by AGORACOM-JC
at 9:49 AM on Thursday, June 10th, 2021
When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.
This led to the enactment of the biggest data privacy laws in history. Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).
Enter $LQID. The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.
More than just lip service, $LQID has made some major announcements, including joining the Trust Over IP Foundation, which includes over 170 members including IBM, Mastercard, Accenture and many other global leaders who are defining a complete architecture for Internet-scale digital trust.
Does that sound like a mouthful? Yeah, it does. But all you have to really understand for now is that digital ID, privacy and monetization is going to become a reality in the very near future. Government regulations are enforcing it. Consumers are demanding it and $LQID is delivering it at such an advanced scale that the Trust Over IP Foundation provided them with a strategic role as a Steering Member.
If that wasn’t enough proof for you, Google validated the $LQID business model with this stunning announcement at the beginning of March:
Google believes these types of tracking methods don’t “meet rising consumer expectations for privacy, nor will they stand up to rapidly evolving regulatory restrictions, and therefore aren’t a sustainable long term investment.”
Google is experimenting with tools in its Privacy Sandbox that are designed to allow advertising to continue to work on the web but in a less privacy-encroaching way.
“Keeping the internet open and accessible for everyone requires all of us to do more to protect privacy — and that means an end to not only third-party cookies, but also any technology used for tracking individual people as they browse the web,” David Temkin, Google’s director of product management for ads privacy and trust,
What is the potential outcome of this major shift by Google?
“Google’s decision could upend the ad industry, which has relied on these types of tracking tools”
Now the data privacy and monetization game is underway with LQID sitting in a great position within the industry and the dominant position within the small cap world.
If consumers are going to switch to Liquid Avatar to protect and monetize their identity, the switch to Digital ID by Canada’s biggest Province is simply a monster catalyst: The Ontario government strategy outlines ways in which it plans to harness the potential of the digital economy and better utilize data. Included in the plan are tangible commitments such as:
the creation of a new data authority;
a new digital artificial intelligence (AI) framework to guide responsible use of AI; and
the introduction of a new government-issued digital ID that lets people prove who they are online.
Cardea is a complete ecosystem that can be used by public health authorities, governments, organizations, and industries to enable people to maintain their privacy while holding and using an easily verifiable, trustworthy, unalterable proof of a health test or vaccination.
One of the first projects to provide the related technology and guidance for implementation of the recently announced Global COVID Certificate Network (GCCN), also from Linux Foundation Public Health, Cardea helps facilitate the safe and free movement of individuals globally during the COVID pandemic.
Watch this interview with CEO David Lucatch for an even deeper discussion into what this all means for $LQID and YOU.
Posted by AGORACOM
at 2:47 PM on Tuesday, June 8th, 2021
Fabled Silver Gold (FCO TSXV) ( FBSGF: OTC ) controls 100% of the Santa Maria mine gold and silver property in Mexico.
What is that and why is that important?
It is a high grade silver gold property that is situated right in the middle of the Mexican Epithermal silver gold belt that has reportedly produced more silver than any other equivalent area in the entire planet.
To say it’s a mining friendly jurisdiction is an understatement.
Multiple major operators are in the vicinity and it’s already got a silver equivalent 43-101 of 3.2m ounces, but is looking to add to that significantly with their recent press release of 2269 g/t silver.
That is not a typo, in other words it is also 2.269 kilos AgEq or 72 troy ounce
2021 Exploration:
Completed 18 holes for 3250m of the increased 9200m program
Hole 20-19 in progress
2nd drill added underground and on 2nd hole
1st underground hole submitted for assay
The Santa Maria Project is poised to deliver as multiple new structures are being investigated and discovered through the ongoing drill program.
Posted by AGORACOM
at 11:32 AM on Tuesday, June 8th, 2021
Posted in Beyond The Press Release, WeedMd | Comments Off on WeedMD $WMD $WDDMFCEO CEO George Scorsis Talks FY2020 Results, Q1 2021 Growth, Inflection Point, & More $CRON $GTBIF $INDS $FAF.ca $WEED.ca
“Novamind, a mental health company that specializes in psychedelic medicine, this week announced revenues of $1.85 million for its fiscal quarter ending March 31, a 43% increase over the prior quarter. With its previously announced plans to open 4 new clinics, doubling the size of its network, between July and September, Novamind said in its earnings report that it expects to increase patient volume to more than 65,000 clinic visits in 2021, which would represent a 225% increase year-over-year.”
“Since listing on the CSE this January, Novamind has demonstrated its ability to rapidly scale access to innovative mental health treatment and psychedelic medicine,” said Yaron Conforti, CEO and Director, Novamind. “The contract with Merck to research a promising new drug, leveraged our expertise in patient recruitment and patient management. Novamind will continue to execute on its aggressive growth initiatives in 2021, further expanding organically and through acquisitions ahead of the FDA’s anticipated approvals of MDMA and psilocybin.”
Identifying the correct dose for therapeutic settings is a crucial step in the path towards optimizing the healing power of psychedelics. In this article, Psychedelic Spotlight details new research studying the optimal LSD dosage for the treatment of mental health disorders. We look forward to more research and clinical trials in the future and will prepare for the time when LSD can be used as a treatment option in our clinics.
The promise of psychedelic medicine is too great to ignore for Campbell Townsend, an Australian-based psychologist who is training in psychedelic-assisted psychotherapy. The Australian government has recently committed $15m to psychedelic clinical trials and support is growing in that country. There is significant momentum growing. Staying at the forefront of psychedelic research, Novamind is currently developing protocols for ketamine-assisted psychotherapy that will standardize and provide best-practice treatment methods for the widespread use of psychedelic medicine.
